Examining the Social Benefits Principle in Research with Human Participants

Health Care Analysis

Volumn 26, Issue 1, 2018, Pages 66-80

  Resnik, David B ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Beneficence; Ethics; Exploitation; Human participant research; Public trust; Risk; Social benefits

Indexed keywords

BENEFICENCE; ETHICS; EXPECTATION; HUMAN; TRUST; BIOETHICS; MEDICAL RESEARCH; PSYCHOLOGY; RESEARCH ETHICS; RESEARCH SUBJECT; STANDARDS;

BENEFICENCE; BIOETHICS; BIOMEDICAL RESEARCH; ETHICS, RESEARCH; HUMANS; RESEARCH SUBJECTS;

EID: 84976870029     PISSN: 10653058     EISSN: 15733394     Source Type: Journal    
DOI: 10.1007/s10728-016-0326-2     Document Type: Article

References (50)

1. Annas, G. J., & Grodin, M. A. (Eds.). (1995). The Nazi doctors and the Nuremberg Code: Human rights in human experimentation. New York: Oxford University Press.
2. Centers for Disease Control and Prevention. (2016). About Zika virus disease. Retrieved from http://www.cdc.gov/zika/about/index.html.
3. Council for the Organizations of Medical Sciences (CIOMS). (2002). International ethical guidelines for biomedical research involving human subjects. Geneva: Council for the Organizations of Medical Sciences.
4. Department of Health and Human Services. (2009). Protection of human subjects. 45 CFR 46.
5. Emanuel, E. J. (2008). Benefits to host countries. In E. J. Emanuel, C. Grady, R. A. Crouch, R. K. Lie, F. G. Miller, & D. Wendler (Eds.), The Oxford handbook of clinical research ethics (pp. 719–728). New York: Oxford University Press.
6. Emanuel, E. J., Wendler, D., & Grady, C. (2000). What makes clinical research ethical? Journal of the American Medical Association, 283(20), 2701–2711.
7. Emanuel, E. J., Wendler, D., Killen, J., & Grady, C. (2004). What makes clinical research in developing countries ethical? The benchmarks of ethical research. Journal of Infectious Diseases, 189(5), 930–937.
8. Feinberg, J. (1986). Harm to self. New York: Oxford University Press.
9. Feinberg, J. (1987). Harm to others. New York: Oxford University Press.
10. Frankena, W. F. (1988). Ethics (2nd ed.). Upper Saddle River: Pearson.
11. Habets, M. G., van Delden, J. J., & Bredenoord, A. L. (2014). The social value of clinical research. BMC Medical Ethics, 5(15), 66.
12. Hawkins, J. S., & Emanuel, E. J. (Eds.). (2008). Exploitation and developing countries: The ethics of clinical research. Princeton: Princeton University Press.
13. Iltis, A. (2007). Pediatric research posing a minor increase over minimal risk and no prospect of direct benefit: challenging 45 CFR 46.406. Accountability in Research, 14(1), 19–34.
14. Kant, I. (1964)[1785]. Groundwork of the metaphysics of morals (H.D, Paton, Trans.). New York: Harper and Rowe.
15. Kekes, J. (2002). On the supposed obligation to relieve famine. Philosophy, 77(302), 503–517.
16. Kitcher, P. (2001). Science, truth, and democracy. New York: Oxford University Press.
17. Kopelman, L. M. (2000). Children as research subjects: A dilemma. Journal of Medicine and Philosophy, 25(6), 745–764.
18. Levine, R. J. (1988). Ethics and regulation of clinical research (2nd ed.). New Haven: Yale University Press.
19. London, A. J. (2003). Threats to the common good: Biological weapons and human subjects research. Hastings Center Report, 33(5), 17–25.
20. London, A. J. (2005). Does research ethics rest on a mistake? The common good, reasonable risk and social justice. American Journal of Bioethics, 5(1), 37–39.
21. London, A. J. (2012). A non-paternalistic model of research oversight: assessing the benefits of prospective review. Journal of Law, Medicine & Ethics, 40(4), 930–944.
22. London, A. J., Kimmelman, J., & Carlisle, B. (2012). Rethinking research ethics: The case of postmarketing trials. Science, 336(6081), 544–545.
23. McCormick, R. A. (1976). Experimentation in children: Sharing sociality. Hastings Center Report, 6(6), 41–46.
24. Miller, F. G., & Wertheimer, A. (2007). Facing up to paternalism in research ethics. Hastings Center Report, 37(3), 24–34.
25. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. (1979). The belmont report: Ethical principles and guidelines for the protection of human subjects of research. Washington, DC: U.S. Department of Health, Education, and Welfare.
26. Needleman, H. L., Reigart, J. R., Landrigan, P., Sass, J., & Bearer, C. (2005). Benefits and risks of pesticide testing on humans. Environmental Health Perspectives, 113(12), A804–A805.
27. Nuremberg Code. (1949). Retrieved from: http://www.hhs.gov/ohrp/archive/nurcode.html.
28. Nussbaum, M. C. (2013). Creating capabilities: The human development approach. Cambridge: Harvard University Press.
29. Ramsey, P. (1976). A reply to Richard McCormick: The enforcement of morals: nontherapeutic research on children. Hastings Center Report, 6(4), 21–30.
30. Rawls, J. (1971). A theory of justice. Cambridge: Harvard University Press.
31. Resnik, D. B. (2008). The social benefits of human subjects research. Journal of Clinical Research Best Practices, 4(11), 1–7.
32. Resnik, D. B. (2009). Playing politics with science. New York, NY: Oxford University Press.
33. Resnik, D. B. (2012). Limits on risks for health volunteers in biomedical research. Theoretical Medicine and Bioethics, 33(2), 137–149.
34. Resnik, D. B., & Portier, C. (2005). Pesticide testing on human subjects: Weight benefits and risks. Environmental Health Perspectives, 113(7), 813–817.
35. Rid, A., & Wendler, D. (2011). A framework for risk-benefit evaluations in biomedical research. Kennedy Institute of Ethics Journal, 21(2), 141–179.
36. Ross, L. F. (2006). Children in medical research: Access versus protection. New York: Oxford University Press.
37. Samuelson, P., & Nordhaus, W. (2009). Economics (19th ed.). New York: McGraw-Hill.
38. Sen, A. J. (1987). On ethics and economics. Oxford: Basil Blackwell.
39. Shah, S. (2006). The body hunters: Testing new drugs on the world’s poorest patients. New York: New Press.
40. Shamoo, A. E., & Resnik, D. B. (2015). Responsible conduct of research (3rd ed.). New York, NY: Oxford University Press.
41. Shuster, E. (1997). Fifty years later: The significance of the Nuremberg Code. New England Journal of Medicine, 337(20), 1436–1440.
42. Singer, P. (1972). Famine, affluence, and morality. Philosophy and Public Affairs, 1(1), 229–243.
43. Sox, H. C., & Rennie, D. (2008). Seeding trials: just say “no”. Annals of Internal Medicine, 149(4), 279–280.
44. Wendler, D. (2010). The ethics of pediatric research. New York: Oxford University Press.
45. Wendler, D. (2013). Do U.S. regulations allow more than minor increase over minimal risk pediatric research? Should they? IRB, 35(6), 1–8.
46. Wendler, D., & Varma, S. (2006). Minimal risk in pediatric research. Journal of Pediatrics, 149(6), 855–861.
47. Wertheimer, A. (1999). Exploitation. Princeton: Princeton University Press.
48. Wertheimer, A. (2015). The social value requirement reconsidered. Bioethics, 29(5), 301–308.
49. World Medical Association. (2013). Declaration of Helsinki: Ethical principles for medical research involving human subjects. Available at: www.wma.net/en/30publications/10policies/b3/. Accessed 1 July 2016.
50. Ziman, J. (2000). Real science. Cambridge: Cambridge University Press.